• Profile
Close

Elevated expression of CAV1 is associated with unfavorable prognosis of patients with breast cancer who undergo surgery and neoadjuvant chemotherapy

Cancer Management and Research Sep 26, 2020

Ye JH, Shi JJ, Yin X, et al. - Researchers examined 80 breast cancer tissue samples for the expression of caveolin-1 (CAV1) using immunohistochemistry (IHC) in order to determine its prognostic significance on patients with breast cancer administered neoadjuvant chemotherapy (NACT). Outcomes revealed correlation of overexpression of CAV1 with shorter disease-free survival and overall survival in patients with breast cancer administered NACT. Hence, they suggest a possible prognostic value of high levels of CAV1 for such patients.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay